Puma Biotechnology (PBYI) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Puma Biotechnology (PBYI) over the last 7 years, with Q3 2025 value amounting to $0.17.
- Puma Biotechnology's EPS (Weighted Average and Diluted) fell 5853.66% to $0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.75, marking a year-over-year increase of 5957.45%. This contributed to the annual value of $0.47 for FY2024, which is 501.38% up from last year.
- According to the latest figures from Q3 2025, Puma Biotechnology's EPS (Weighted Average and Diluted) is $0.17, which was down 5853.66% from $0.12 recorded in Q2 2025.
- In the past 5 years, Puma Biotechnology's EPS (Weighted Average and Diluted) registered a high of $0.41 during Q3 2024, and its lowest value of -$1.09 during Q3 2021.
- Over the past 5 years, Puma Biotechnology's median EPS (Weighted Average and Diluted) value was $0.06 (recorded in 2025), while the average stood at $0.03.
- As far as peak fluctuations go, Puma Biotechnology's EPS (Weighted Average and Diluted) surged by 130000.0% in 2023, and later crashed by 43333.33% in 2024.
- Over the past 5 years, Puma Biotechnology's EPS (Weighted Average and Diluted) (Quarter) stood at $0.1 in 2021, then tumbled by 224.77% to -$0.12 in 2022, then soared by 300.37% to $0.25 in 2023, then decreased by 0.37% to $0.25 in 2024, then crashed by 31.75% to $0.17 in 2025.
- Its EPS (Weighted Average and Diluted) was $0.17 in Q3 2025, compared to $0.12 in Q2 2025 and $0.06 in Q1 2025.